Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study
- PMID: 3385016
- DOI: 10.1002/cne.902710405
Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study
Abstract
Although glucagonlike immunoreactants (GLIs) are present in the central nervous system of several mammalian species, their structural relationship with pancreatic proglucagon is not defined, and their precise anatomical distribution has not been studied extensively. To obtain further information about the structure and biological significance of brain GLIs, the anatomical distribution of three different antigenic determinants of pancreatic proglucagon--glucagonlike peptide I (GLP-I), glucagon, and glicentin--was mapped in the brain of colchicine-treated rats by immunocytochemistry using the avidin-biotin-peroxidase method. Neuronal cell bodies immunoreactive with antisera specific for GLP-I, glucagon, and glicentin were found only in the caudal medulla oblongata. Within the caudal medulla immunostained cell bodies were found at levels from approximately 0.55 mm rostral to the obex to 0.45 mm caudal to the obex, and were located within the nucleus of the solitary tract (NTS) and the dorsal (MdD) and ventral (MdV) parts of the medullary reticular nucleus. The NTS contained three times more immunoreactive cell bodies than the MdD and MdV, and these cell bodies were located in the midline, medial, and lateral subnuclei of the caudal third of the NTS. Immunostaining of the same cell bodies in paired adjacent sections incubated with GLP-I and glucagon antisera or glucagon and glicentin antisera provided evidence for coexistence of the three antigens within the same neurons of the NTS. Nerve fibers and terminals immunoreactive with GLP-I, glucagon, and glicentin antisera were widely distributed throughout the rat brain and there was no discernible difference in the distribution of fibers and terminals immunoreactive with each of the three antisera. The highest densities of immunostained fibers and terminals were observed in the hypothalamus, thalamus, and septal regions, and the lowest in the cortex and hindbrain. The localization of neuronal cell bodies containing GLP-I, glucagon, and glicentin within the NTS and the MdD and MdV, and the extensive distribution of immunoreactive fibers and terminals throughout the rat brain suggest a role for these peptides in the integration of autonomic as well as central nervous system functions.
Similar articles
-
Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain.J Neurosci Res. 1986;16(1):97-107. doi: 10.1002/jnr.490160110. J Neurosci Res. 1986. PMID: 2427741
-
Neuropeptide Y-immunoreactive perikarya and nerve terminals in the rat medulla oblongata: relationship to cytoarchitecture and catecholaminergic cell groups.J Comp Neurol. 1987 Jun 1;260(1):20-35. doi: 10.1002/cne.902600103. J Comp Neurol. 1987. PMID: 2885349
-
Distribution of neuropeptide immunoreactive nerve terminals within the subnuclei of the nucleus of the tractus solitarius of the rat.J Comp Neurol. 1984 Jan 20;222(3):409-44. doi: 10.1002/cne.902220308. J Comp Neurol. 1984. PMID: 6199382
-
Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin--current status.Gastroenterology. 1983 Jun;84(6):1602-13. Gastroenterology. 1983. PMID: 6188645 Review.
-
The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective.Front Endocrinol (Lausanne). 2021 Jun 11;12:683089. doi: 10.3389/fendo.2021.683089. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34177808 Free PMC article. Review.
Cited by
-
Preproglucagon (PPG) neurons innervate neurochemically identified autonomic neurons in the mouse brainstem.Neuroscience. 2013 Jan 15;229:130-43. doi: 10.1016/j.neuroscience.2012.09.071. Epub 2012 Oct 13. Neuroscience. 2013. PMID: 23069752 Free PMC article.
-
Glucagon's Metabolic Action in Health and Disease.Compr Physiol. 2021 Apr 1;11(2):1759-1783. doi: 10.1002/cphy.c200013. Compr Physiol. 2021. PMID: 33792899 Free PMC article.
-
The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors.Neuropsychopharmacology. 2016 Feb;41(3):906-15. doi: 10.1038/npp.2015.220. Epub 2015 Jul 27. Neuropsychopharmacology. 2016. PMID: 26211731 Free PMC article.
-
GLP-1 based therapeutics: simultaneously combating T2DM and obesity.Front Neurosci. 2015 Mar 20;9:92. doi: 10.3389/fnins.2015.00092. eCollection 2015. Front Neurosci. 2015. PMID: 25852463 Free PMC article. Review.
-
The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review.Dig Dis Sci. 2007 Mar;52(3):643-9. doi: 10.1007/s10620-006-9096-2. Dig Dis Sci. 2007. PMID: 17268838 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
